Literature DB >> 16600389

Genetic diseases associated with heterotrimeric G proteins.

Lee S Weinstein1, Min Chen, Tao Xie, Jie Liu.   

Abstract

Heterotrimeric G proteins couple receptors for diverse extracellular signals to effector enzymes or ion channels. Each G protein comprises a specific alpha-subunit and a tightly bound betagamma dimer. Several human disorders that result from genetic G-protein abnormalities involve the imprinted GNAS gene, which encodes Gs alpha, the ubiquitously expressed alpha-subunit that couples receptors to adenylyl cyclase and cAMP generation. Loss-of-function and gain-of-function mutations, in addition to imprinting defects, of this gene lead to diverse clinical phenotypes. Mutations of GNAT1 and GNAT2, which encode the retinal G proteins (transducins), are rare causes of specific congenital visual defects. Common polymorphisms of the GNAS and GNB3 (which encodes Gbeta3) genes have been associated with multigenic disorders (e.g. hypertension and metabolic syndrome). To date, no other G proteins have been implicated directly in human disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16600389     DOI: 10.1016/j.tips.2006.03.005

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  39 in total

1.  Design of cyclic peptides that bind protein surfaces with antibody-like affinity.

Authors:  Steven W Millward; Stephen Fiacco; Ryan J Austin; Richard W Roberts
Journal:  ACS Chem Biol       Date:  2007-09-21       Impact factor: 5.100

2.  Regulation of cAMP responses by the G12/13 pathway converges on adenylyl cyclase VII.

Authors:  Lily I Jiang; Julie Collins; Richard Davis; Iain D Fraser; Paul C Sternweis
Journal:  J Biol Chem       Date:  2008-06-09       Impact factor: 5.157

3.  Heterozygous inactivation of Gnas in adipose-derived mesenchymal progenitor cells enhances osteoblast differentiation and promotes heterotopic ossification.

Authors:  Robert J Pignolo; Meiqi Xu; Elizabeth Russell; Alec Richardson; Josef Kaplan; Paul C Billings; Frederick S Kaplan; Eileen M Shore
Journal:  J Bone Miner Res       Date:  2011-11       Impact factor: 6.741

4.  The stimulatory G protein Gsα is required in melanocortin 4 receptor-expressing cells for normal energy balance, thermogenesis, and glucose metabolism.

Authors:  Brandon Podyma; Hui Sun; Eric A Wilson; Bradley Carlson; Ethan Pritikin; Oksana Gavrilova; Lee S Weinstein; Min Chen
Journal:  J Biol Chem       Date:  2018-05-24       Impact factor: 5.157

Review 5.  The role of GNAS and other imprinted genes in the development of obesity.

Authors:  L S Weinstein; T Xie; A Qasem; J Wang; M Chen
Journal:  Int J Obes (Lond)       Date:  2009-10-20       Impact factor: 5.095

6.  GNAS gene variants affect β-blocker-related survival after coronary artery bypass grafting.

Authors:  Ulrich H Frey; Jochen D Muehlschlegel; Jürgen Peters; Simon Body; Christoph Ochterbeck; Amanda A Fox; Stanton K Shernan; Charles D Collard; Peter Lichtner
Journal:  Anesthesiology       Date:  2014-05       Impact factor: 7.892

Review 7.  Pharmacogenomics of beta-adrenergic receptors and their accessory signaling proteins in heart failure.

Authors:  Gerald W Dorn; Stephen B Liggett
Journal:  Clin Transl Sci       Date:  2008-12       Impact factor: 4.689

8.  Development and treatment of tertiary hyperparathyroidism in patients with pseudohypoparathyroidism type 1B.

Authors:  Nicola M Neary; Diala El-Maouche; Rachel Hopkins; Steven K Libutti; Arnold M Moses; Lee S Weinstein
Journal:  J Clin Endocrinol Metab       Date:  2012-06-26       Impact factor: 5.958

9.  Gsα deficiency in the paraventricular nucleus of the hypothalamus partially contributes to obesity associated with Gsα mutations.

Authors:  Min Chen; Alta Berger; Ahmed Kablan; Jiandi Zhang; Oksana Gavrilova; Lee S Weinstein
Journal:  Endocrinology       Date:  2012-06-25       Impact factor: 4.736

10.  Different roles of GNAS and cAMP signaling during early and late stages of osteogenic differentiation.

Authors:  S Zhang; F S Kaplan; E M Shore
Journal:  Horm Metab Res       Date:  2012-08-17       Impact factor: 2.936

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.